 Toan Ong
Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Medical Record Linkage | 5 | 2024 | 69 | 2.120 |
Why?
| | Influenza Vaccines | 15 | 2026 | 541 | 1.980 |
Why?
| | Influenza, Human | 14 | 2026 | 634 | 1.920 |
Why?
| | Hospitalization | 35 | 2026 | 2496 | 1.510 |
Why?
| | Emergency Service, Hospital | 23 | 2025 | 2416 | 1.250 |
Why?
| | Electronic Health Records | 5 | 2024 | 1214 | 0.870 |
Why?
| | Ambulatory Care | 10 | 2025 | 625 | 0.850 |
Why?
| | Immunization, Secondary | 4 | 2022 | 93 | 0.820 |
Why?
| | Population Surveillance | 3 | 2025 | 486 | 0.770 |
Why?
| | Algorithms | 3 | 2024 | 1868 | 0.630 |
Why?
| | Heart Defects, Congenital | 4 | 2020 | 941 | 0.600 |
Why?
| | Vaccination | 16 | 2026 | 1443 | 0.550 |
Why?
| | Child Abuse | 1 | 2024 | 558 | 0.540 |
Why?
| | Referral and Consultation | 1 | 2024 | 886 | 0.520 |
Why?
| | Influenza A Virus, H3N2 Subtype | 6 | 2026 | 50 | 0.500 |
Why?
| | Data Mining | 1 | 2017 | 114 | 0.480 |
Why?
| | United States | 31 | 2026 | 16313 | 0.470 |
Why?
| | Pregnancy Complications, Infectious | 3 | 2025 | 442 | 0.460 |
Why?
| | Adult | 43 | 2026 | 41405 | 0.450 |
Why?
| | Mass Screening | 1 | 2024 | 1375 | 0.450 |
Why?
| | Adolescent | 34 | 2026 | 22825 | 0.450 |
Why?
| | Seasons | 9 | 2026 | 540 | 0.410 |
Why?
| | Humans | 64 | 2026 | 147293 | 0.380 |
Why?
| | Medical Informatics | 1 | 2014 | 100 | 0.380 |
Why?
| | Biomedical Research | 2 | 2017 | 723 | 0.330 |
Why?
| | Case-Control Studies | 11 | 2026 | 3660 | 0.330 |
Why?
| | Outpatients | 3 | 2022 | 450 | 0.320 |
Why?
| | Young Adult | 21 | 2026 | 14437 | 0.310 |
Why?
| | Aged | 21 | 2026 | 26514 | 0.290 |
Why?
| | Middle Aged | 25 | 2026 | 36821 | 0.290 |
Why?
| | Influenza A Virus, H1N1 Subtype | 3 | 2025 | 162 | 0.270 |
Why?
| | Aged, 80 and over | 10 | 2026 | 8430 | 0.260 |
Why?
| | Female | 31 | 2026 | 80076 | 0.250 |
Why?
| | Male | 29 | 2026 | 73950 | 0.250 |
Why?
| | Child, Preschool | 11 | 2026 | 12016 | 0.240 |
Why?
| | Critical Illness | 2 | 2023 | 907 | 0.240 |
Why?
| | Vaccines, Combined | 5 | 2023 | 49 | 0.240 |
Why?
| | Research Design | 3 | 2025 | 1157 | 0.230 |
Why?
| | Child | 16 | 2026 | 22979 | 0.220 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2020 | 2627 | 0.220 |
Why?
| | Antiviral Agents | 3 | 2026 | 776 | 0.220 |
Why?
| | Colorado | 4 | 2024 | 4591 | 0.220 |
Why?
| | Vaccines, Synthetic | 5 | 2022 | 137 | 0.220 |
Why?
| | RNA, Messenger | 8 | 2024 | 2812 | 0.220 |
Why?
| | Indiana | 1 | 2024 | 38 | 0.210 |
Why?
| | Infant | 8 | 2026 | 10194 | 0.210 |
Why?
| | Data Accuracy | 1 | 2024 | 65 | 0.210 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2024 | 39 | 0.210 |
Why?
| | Physical Abuse | 1 | 2024 | 41 | 0.200 |
Why?
| | Child Protective Services | 1 | 2024 | 65 | 0.200 |
Why?
| | Drug Prescriptions | 1 | 2025 | 293 | 0.190 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2024 | 140 | 0.190 |
Why?
| | Diabetes Mellitus, Type 1 | 4 | 2020 | 3952 | 0.190 |
Why?
| | Viral Vaccines | 1 | 2023 | 107 | 0.180 |
Why?
| | Influenza B virus | 3 | 2026 | 47 | 0.170 |
Why?
| | Information Dissemination | 1 | 2023 | 227 | 0.160 |
Why?
| | Immunocompromised Host | 1 | 2021 | 202 | 0.150 |
Why?
| | India | 4 | 2020 | 221 | 0.150 |
Why?
| | Probability | 1 | 2020 | 309 | 0.150 |
Why?
| | Information Storage and Retrieval | 1 | 2020 | 123 | 0.140 |
Why?
| | Diabetic Ketoacidosis | 1 | 2020 | 212 | 0.130 |
Why?
| | Infant, Newborn | 3 | 2024 | 6543 | 0.120 |
Why?
| | Comparative Effectiveness Research | 1 | 2017 | 170 | 0.120 |
Why?
| | Practice Patterns, Physicians' | 1 | 2025 | 1379 | 0.120 |
Why?
| | Antibodies, Neutralizing | 3 | 2022 | 345 | 0.110 |
Why?
| | Retrospective Studies | 5 | 2025 | 17560 | 0.110 |
Why?
| | Databases, Factual | 2 | 2019 | 1504 | 0.110 |
Why?
| | Mental Disorders | 1 | 2024 | 1188 | 0.110 |
Why?
| | Models, Theoretical | 1 | 2017 | 563 | 0.100 |
Why?
| | Hospital Mortality | 3 | 2023 | 1043 | 0.100 |
Why?
| | Antibodies, Monoclonal | 3 | 2022 | 1514 | 0.080 |
Why?
| | Registries | 4 | 2020 | 2434 | 0.080 |
Why?
| | Laboratories | 2 | 2021 | 111 | 0.080 |
Why?
| | Hospitals | 2 | 2024 | 740 | 0.070 |
Why?
| | Pregnancy | 3 | 2025 | 7274 | 0.060 |
Why?
| | Immunity, Herd | 1 | 2024 | 7 | 0.050 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2024 | 81 | 0.050 |
Why?
| | Spermine | 1 | 2023 | 29 | 0.050 |
Why?
| | RNA, Messenger, Stored | 1 | 2022 | 7 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 379 | 0.050 |
Why?
| | Stakeholder Participation | 1 | 2023 | 89 | 0.050 |
Why?
| | Advisory Committees | 1 | 2024 | 233 | 0.040 |
Why?
| | Patient Outcome Assessment | 1 | 2023 | 130 | 0.040 |
Why?
| | Vaccination Coverage | 1 | 2023 | 106 | 0.040 |
Why?
| | Treatment Failure | 1 | 2022 | 360 | 0.040 |
Why?
| | Immunization Schedule | 1 | 2021 | 186 | 0.040 |
Why?
| | Insurance Claim Reporting | 1 | 2020 | 26 | 0.040 |
Why?
| | Computer Simulation | 1 | 2025 | 1018 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 11017 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 323 | 0.040 |
Why?
| | Logistic Models | 1 | 2025 | 2142 | 0.040 |
Why?
| | Patient Participation | 1 | 2023 | 449 | 0.040 |
Why?
| | Demography | 1 | 2020 | 283 | 0.040 |
Why?
| | Bias | 1 | 2020 | 201 | 0.040 |
Why?
| | Ambulatory Care Facilities | 1 | 2021 | 269 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 568 | 0.030 |
Why?
| | Linear Models | 1 | 2019 | 852 | 0.030 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2022 | 1005 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1342 | 0.030 |
Why?
| | Patient Readmission | 1 | 2021 | 777 | 0.030 |
Why?
| | Models, Statistical | 1 | 2019 | 677 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 928 | 0.030 |
Why?
| | Cross-Sectional Studies | 1 | 2025 | 6011 | 0.020 |
Why?
| | Incidence | 1 | 2020 | 2954 | 0.020 |
Why?
| | Prevalence | 1 | 2019 | 2889 | 0.020 |
Why?
| | Cohort Studies | 1 | 2023 | 6099 | 0.020 |
Why?
| | Prognosis | 1 | 2020 | 4383 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2020 | 5476 | 0.020 |
Why?
| | Time Factors | 1 | 2022 | 7173 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3149 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2020 | 11947 | 0.010 |
Why?
|
|
Ong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|